[1]

LUO Wen, WU Jing, HE Dake, YANG Rui. One Case of Dermatitis Medicamentosa in a Paediatric Epilepsy Patient Caused by Lacosamide Oral Solution [J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 452-455.

[2]

YU Jing, PALATI Reheman, ZHAO Ting, FENG Jirong, SUN Yan, HE Lei. Correlation of the efficacy, safety and plasma concentration of lacosamide in the treatment of children with epilepsy under 4 years of age [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 559-562.

[3]

JIANG Wenshuo, YANG Li. Adverse drug reaction among 694 patients in an epilepsy physician-pharmacist joint clinic [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 102-106.

[4]

WANG Qiru, ZUO Li, DU Qiong, YE Ling, RUAN Cong, ZHAI Qing, XU Rui. Pharmaceutical care of a patient with grade Ⅳ myelosuppression induced by olapalil [J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1176-1180.

[5]

LIANG Dong, LUO Li, CHENG Junxiang. Adverse reactions caused by levetiracetam [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1054-1059.

[6]

WANG Chun-ting, ZHENG Ming-jie. Risk Analysis and Measures of Fetal Skeletal Abnormalities Caused by Magnesium Sulfate Injection [J]. Chinese Journal of Pharmacovigilance, 2014, 11(7): 429-431.

[7]

. [J]. Chinese Journal of Pharmacovigilance, 2014, 11(2): 121-121.

[8]

. [J]. Chinese Journal of Pharmacovigilance, 2014, 11(1): 59-59.

[9]

. [J]. Chinese Journal of Pharmacovigilance, 2013, 10(10): 635-635.

[10]

LI Zheng-ran ,ZHU Yue-ting ,GAO Chen, HUANG Jia, LI Ji-yang ,CUI Xiang-li. Analysis of Blood Concentrations of Sodium Valproate in 248 Cases of Perioperative Patients with Brain Tumors [J]. Chinese Journal of Pharmacovigilance, 2013, 10(9): 520-522.

[11]

[12]

. [J]. Chinese Journal of Pharmacovigilance, 2010, 7(4): 250-250.

PDF (PC)

Knowledge